Incyte (INCY) has been quietly outperforming the broader biotech space this year, with the stock up about 46% over the past year and more than 40% year to date, drawing fresh attention. See our latest ...

Fintel reports that on December 8, 2025, Mizuho upgraded their outlook for Incyte (NasdaqGS:INCY) from Neutral to Outperform. Analyst Price Forecast Suggests 6.11% Downside As of December 6, 2025, the ...

Barclays analyst Etzer Darout maintained a Buy rating on Incyte today and set a price target of $115.00. Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest ...

Male nursery web spiders (Pisaura mirabilis) use the sense of smell in their legs to find mates. Researchers at the University of Greifswald used an electron microscope to discover "olfactory hairs" ...

Incyte (INCY) shares have shown solid momentum over the past month, gaining 12% and delivering a 21% return over the past 3 months. The company continues to draw investor attention for its performance ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Incyte Corporation (NASDAQ:INCY) ranks among the best biotech stocks to buy. RBC Capital retained its Sector Perform rating on Incyte Corporation (NASDAQ:INCY) and increased its price target from $72 ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. Incyte Corporation is one of them. Incyte Corporation (NASDAQ:INCY), a global biopharmaceutical ...

Fintel reports that on August 6, 2025, Wells Fargo upgraded their outlook for Incyte (NasdaqGS:INCY) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 6.78% Upside As of August 6, 2025, ...

A millennial dad called on an unlikely source to help get his daughter to sleep. Kevin Cooney (@kevincooneyy) from Boston, Massachusetts, posted a video on TikTok while bottle-feeding his baby and ...